Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01783834
What this trial is testing

Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients

Who this might be right for
Previous Treated Metastatic Non-small Cell Lung Cancer
Gachon University Gil Medical Center 95
Testing effectiveness (Phase 2)Study completedNCT02013206
What this trial is testing

Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT00021333
What this trial is testing

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Fox Chase Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01291017
What this trial is testing

Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.

Who this might be right for
Non-small Cell Lung Cancer
University of Florida 19
Testing effectiveness (Phase 2)Study completedNCT01068587
What this trial is testing

MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 31
Testing effectiveness (Phase 2)Study completedNCT01022671
What this trial is testing

Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Chong Kun Dang Pharmaceutical 52
Testing effectiveness (Phase 2)Study completedNCT00638937
What this trial is testing

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT02864394
What this trial is testing

Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 425
Large-scale testing (Phase 3)Ended earlyNCT03626545
What this trial is testing

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

Who this might be right for
Non-Small-Cell Lung
Novartis Pharmaceuticals 245
Testing effectiveness (Phase 2)Looking for participantsNCT05631249
What this trial is testing

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

Who this might be right for
KRAS P.G12CNon Small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05555732
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo 1,170
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393555
What this trial is testing

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
SWOG Cancer Research Network 117
Testing effectiveness (Phase 2)Ended earlyNCT00611650
What this trial is testing

Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia

Who this might be right for
Lung CancerPrecancerous ConditionTobacco Use Disorder
British Columbia Cancer Agency 23
Early research (Phase 1)Study completedNCT01784640
What this trial is testing

Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IV Non-small Cell Lung Cancer
Jonsson Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT01530334
What this trial is testing

Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment

Who this might be right for
Lung Cancer
AstraZeneca 61
Testing effectiveness (Phase 2)Study completedNCT03242915
What this trial is testing

Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents

Who this might be right for
Non-small Cell Lung Cancer
University of Michigan Rogel Cancer Center 33
Early research (Phase 1)Ended earlyNCT02460367
What this trial is testing

Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerProgression of Non-small Cell Lung CancerNon-small Cell Lung Cancer Recurrent
NewLink Genetics Corporation 16
Testing effectiveness (Phase 2)Ended earlyNCT00077064
What this trial is testing

Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy

Who this might be right for
Lung CancerPulmonary ComplicationsRadiation Fibrosis
Radiation Therapy Oncology Group 81
Testing effectiveness (Phase 2)Study completedNCT00124280
What this trial is testing

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small-cell Lung Carcinoma
Novartis Pharmaceuticals 85
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Next Page